CGT R&D and Industrialization Base Signing Ceremony

Strong alliance signed and set sail

At the signing ceremony, both parties had a discussion and exchange, expressing their firm confidence and shared vision for future cooperation. Both parties agree that this signing is not only an important opportunity to deepen the partnership, but also a crucial step in expanding deep cooperation in multiple fields and modes, injecting new impetus and vitality into the high-quality development of Hangzhou Airport Economic Demonstration Zone.

Wu Weiwei, Executive Deputy Director of Hangzhou Airport Economic Demonstration Zone Management Committee

Mr. Wu Weiwei warmly welcomed Jiete Biotechnology's entry into the airport.He said,As a leading enterprise in the domestic biological laboratory consumables industry, Jiete Biotechnology's entry not only enhances the industrial ecology of the park, but also further strengthens the confidence of both parties in cooperation.In recent years, the demonstration zone has focused on the "2+3" modern aviation industry system, and has planned a biopharmaceutical park with an area of 8.93 square kilometers. The first phase of the park has begun to take shape and will continue to expand its industrial carrying capacity in the future. This signing is the starting point for mutual benefit. Lingkong will continue to optimize its business environment, provide comprehensive service guarantees, and rely on Hangzhou's superior talent policies and innovative ecology to fully support Jiete Biotechnology in achieving long-term development in Lingkong. Through practical cooperation, we will jointly promote Lingkong to become a new highland for high-quality development of the biopharmaceutical industry with international competitiveness.

Yuan Ye, Director and General Manager of Guangzhou Jiete Biological Filtration Co., Ltd

Mr. Yuan Ye highly praised the service quality of Hangzhou Airport Economic Demonstration Zone, which is enthusiastic, thoughtful, professional, efficient, pragmatic, and persistent.He stated that the demonstration zone is the first stop for Jiete Biotechnology's investigation of Hangzhou. Its open and inclusive attitude, precise and pragmatic measures are impressive, and vividly demonstrate Hangzhou's first-class business environment.Jiete Biotechnology will take this signing as an opportunity to grow vigorously in the innovative and dynamic "development fertile land" of Linkong, achieve leapfrog growth in the two-way pursuit of technology research and development and market development, resonate and promote regional development, and work together to write a new chapter of win-win cooperation.

Guangzhou Jiete Biological Filtration Co., Ltd

Falling in the air, gathering momentum CGT

Jiete Biotechnology, as the first stock listed on the Science and Technology Innovation Board of China's biological laboratory consumables, is deeply involved in life sciences20Years have passed, already possessing12000+Products and supporting equipment, including biological laboratory consumables, biological process consumables, biological reagents, laboratory instruments, medical devices, etc., are widely used in fields such as biological research, biomedicine, molecular diagnosis, cell therapy, etc., and exported to Europe and America70Multiple countries and regions. The company has mastered multiple key core technologies and advanced production processes for biological laboratory consumables, and possessespatent227Among them, there are 37 invention patents, andWon the China Patent Award for four consecutive yearsAt the same time, it also led the development of 2 provincial standards, 24 group standards, participated in the development of 1 national standard, and 3 industry standards.

The companies signed this time, Zhongsai Botai Biotechnology (Hangzhou) Co., Ltd. and Jieke Membrane Filtration Technology (Hangzhou) Co., Ltd., are the controlling subsidiaries of Jiete Biotechnology.Relying on the industrial accumulation of its parent company, it focuses on intelligent manufacturing of CGT (cell and gene therapy) and overall solutions for biological filtrationOur core business covers intelligent process equipment, consumables, and software such as disposable bioreactors, ultrafiltration systems, continuous flow centrifugation systems, and automated cell workstations. We integrate research, production, and sales, and provide customized services for the preparation of biological products such as CGT, vaccines, and antibodies. We have significant advantages in system compatibility, process continuity, and cost control, which can shorten cycles and reduce costs.

According to the plan, Jiete Biotechnology will establish a regional research and development center and industrialization base in the Hangzhou Airport Economic Demonstration Zone. The first phase of the project will be located in Chengzhou District, Hangzhou Biotechnology Valley.The implementation of this project will greatly enhance the strength of the airborne CGT intelligent equipment chain group, forming a complete industrial chain from consumables to equipment to software, further attracting high-quality upstream and downstream enterprises to gather, and has important demonstration significance for promoting the high-quality development of the airborne biopharmaceutical industry.

Disclaimer: The content and image materials of the article are sourced from“Hangzhou Airport Economic Demonstration Zoneofficial accountFor information reference only, our company does not assume any legal liability for infringement.